+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue



Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue



Journal of Infectious Diseases 217(2): 177-178




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059900621

Download citation: RISBibTeXText

PMID: 29136167

DOI: 10.1093/infdis/jix499


Related references

The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination. Vaccine 26(35): 4513-4518, 2008

Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature. Journal of the Pediatric Infectious Diseases Society 6(4): 380-385, 2017

Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatric Infectious Disease Journal 27(2): 149-154, 2008

Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP). Virology 188(1): 384-387, 1992

Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. Journal of Clinical Microbiology 35(12): 3098-3103, 1997

Nucleotide and phylogenetic analysis of human papillomavirus type 11 isolated from juvenile-onset recurrent respiratory papillomatosis in China. Journal of Medical Virology 88(4): 686-694, 2016

Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report. International Journal of Pediatric Otorhinolaryngology 91: 166-169, 2017

A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program. Journal of Infectious Diseases 217(2): 208-212, 2017

Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study. Sexual Health 7(3): 253-261, 2010

Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis. Laryngoscope 2019, 2019

Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis. Oncologist 2019, 2019

Two cases of juvenile-onset and adult-onset recurrent respiratory papillomatosis. Nihon Kokyuki Gakkai Zasshi 49(9): 667-673, 2011

A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102(1): 9-13, 1992

Juvenile-Onset Recurrent Respiratory Papillomatosis. Pediatric Asthma Allergy & Immunology 15(1): 59-62, 2001

Recurrent Respiratory Papillomatosis (RRP)-Juvenile Onset. Clinical Medicine. Oncology 2: 481-486, 2008